The role of melatonin in the complex treatment of patients with gastroesophageal reflux disease with sleep apnea syndrome

Prof. A.G. Oparin, M.A. Murghuzov

Kharkiv Medical Academy of Postgraduate Education

The study showed that the inclusion of melatonin in the standard treatment regimen for patients with GERD with concomitant obstructive sleep apnea syndrome is not only clinically justified, it also shortens the onset of clinical remission of both the main and concomitant pathologies, with a high degree of certainty it increases the level of patients’ QOL, especially mental scales health, but also pathogenetically justified, as it has a positive effect on eliminating the imbalance in the melatonin-endothelin system, reducing the aggression of gastric juice and increasing factor protection lining of the esophagus and stomach.

Key Words: gastroesophageal reflux disease, Melatonin, Endothelin-1, QOL, Acidity, Obstructive Sleep Apnea Syndrome.

https://dx.doi.org/10.15407/internalmed2020.01.111

Download.PDF (rus)

For citing:

1. Опарин, А.Г. Роль препарата мелатонина в комплексной терапии пациентов с гастроэзофагеальной рефлюксной болезнью и с синдромом ночного апноэ сна / А.Г. Опарин, М.А. Мургузов // Східноєвропейський журнал внутрішньої та сімейної медицини. – 2020. – № 1. – С. 111-114. doi: 10.15407/internalmed2020.01.111

2.  Oparin AG, Murghuzov MA. [The role of melatonin in the complex treatment of patients with gastroesophageal reflux disease with sleep apnea syndrome]. Shidnoevr. z. vnutr. simejnoi med. 2020;1:111-114. doi: 10.15407/internalmed2020.01.111. Russian.

References:

1. Bespjatyh AJu, Brodskij VJa, Burlakova OV, Golichenkov VA, Voznesenskaja LA, Kolesnikov DB, Molchanov AJu, Rapoport SI. Melatonin: teorija i praktika. Moskow: Medpraktika;2009. 100 р. Russian. ISBN: 978-5-98803-163-5

2. Golubev AV. Biohimija prodlenija zhizni. Uspehi gerontologii. 2003;12:57-76. Russian.
https://doi.org/10.1023/A:1023367127394

3. Zhukova TV. Gastrojezofageal’naja refljuksnaja bolezn': vnepishhevodnye projavlenija, metody diagnostiki i korrekcii. Medicinskie novosti. 2013; 11:4-8. Russian.

4. Ivashkin VT, Truhmanov AS, Sheptulin AA Maev IV, Baranskaja EK, Dronova OB, Zajrat’janc OV, Sajfutdinov RG, Lapina TN, Pirogov SS, Kucherjavyj JuA, Storonova OA, Andreev DN. Gastrojezofageal’naja refljuksnaja bolezn’. Rekomendacii po diagnostike i lecheniju. Moskow; 2013. 20 р. Russian.

5. Karpovich OA. Protektornaja rol’ melatonina pri gastrojezofageal’noj refljuksnoj bolezni. Gepatologija i gastrojenterologija. 2019;1:61-65. Russian. https://doi.org/10.25298/2616-5546-2019-3-1-61-65
https://doi.org/10.25298/2616-5546-2019-3-1-61-65

6. Kamenir VM. Rol’ azota i melatonina v patogeneze gastrojezofagefl’noj refljuksnoj bolezni. Suchasna hastroеnterolohiia. 2009;2:125-128. Russian.

7. Lazebnik LB. Izzhoga i gastrojezofageal’naja refljuksnaja bolezn': problemy i reshenija. Terapevticheskij arhiv. 2008;5-11. Russian.

8. Malinovskaja NK. Melatonin: vchera, segodnja, zavtra. Klinicheskaja medicina. 2002;6:71-73. Russian.

9. Svijarev JuV, Korostovceva LS, Zvartau NJe. Prognosticheskoe znachenie sindroma obstruktivnogo apnoje vo sne: promezhutochnye rezul’taty pjati letnogo prospektivnogo nabljudenija. Arterial’naja gipertonija. 2011;1:10-16. Russian.

10. Spavsova TE, Hitriheeva VE, Batudaeva TI, Soktoeva BV. Faktory riska razvitija vnepishhevodnyh projavlenij gastrojezofageal’noj refljuksnoj bolezni. Acta Biomedica Scientifica. 2017;2(6):12-20. Russian.
https://doi.org/10.12737/article_5a0a7e8b546824.43326346

11. Fadeenko GD, Gridnev AE. Gastrojezofageal’naja refljuksnaja bolezn': pishhevodnye i vnepishhevodnye projavlenija i komorbidnost’. Kyiv;2012. 367 р. Russian.

12. Demeter P, Pap A. The relationship between gastroesophageal reflux disease and obstructive sleep apnea. Journal of Gastroenterology. 2004;39(9):815-820. http://dx.doi.org/10.1007/s00535-004-1416-8
https://doi.org/10.1007/s00535-004-1416-8

13. Demirdaş A, Nazıroğlu M, Ünal G. Agomelatine reduces brain, kidney and liver oxidative stress but increases plasma cytokine production in the rats with chronic mild stress-induced depression. Metabolic Brain Disease. 2016;31(6):1445-1453. http://dx.doi.org/10.1007/s11011-016-9874-2
https://doi.org/10.1007/s11011-016-9874-2

14. Konturek SJ, Konturek PC, Brzozowski T, Bubenik GA. Role of melatonin in upper gastrointestinal tract. Physiology and Pharm. 2007;58(6):23-32.

15. Konturek SJ, Konturek PC, Brzozowski T. Localization and biological activities of melatonin in intact and diseased gastrointestinal tract. Physiology and Pharm. 2007;57(3):381-405.

16. Lindam A, Kendall B, Thrift A, Macdonald G, O’Brien S, Lagergren J, Whiteman D. Symptoms of Obstructive Sleep Apnea, Gastroesophageal Reflux and the Risk of Barrett’s Esophagus in a Population-Based Case-Control Study. PLOS ONE. 2015;10(6):e0129836. http://dx.doi.org/10.1371/journal.pone.0129836
https://doi.org/10.1371/journal.pone.0129836

17. Tan D, Reiter R, Calvo J, Manchester L. Antioxidative Capacity of Melatonin. Handbook of Antioxidants. 2002;565-613. http://dx.doi.org/10.1201/9780203904046.pt8
https://doi.org/10.1201/9780203904046.pt8

18. Sereda NN. Gastrojezofagealnaja refljuksnaja bolezn [Gastroesophageal reflux disease]. Sibirskij medicinskij zhurnal [Siberian Medical Journal]. 2014;127(4):133-139.

19. Sjöblom M, Jedstedt G, Flemström G. Peripheral melatonin mediates neural stimulation of duodenal mucosal bicarbonate secretion. Journal of Clinical Investigation. 2001;108(4):625-633. http://dx.doi.org/10.1172/jci13052
https://doi.org/10.1172/JCI13052

20. Tufik S, Santos-Silva R, Taddei J, Bittencourt L. Obstructive Sleep Apnea Syndrome in the Sao Paulo Epidemiologic Sleep Study. Sleep Medicine. 2010;11(5):441-446. http://dx.doi.org/10.1016/j.sleep.2009.10.005.
https://doi.org/10.1016/j.sleep.2009.10.005